These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 2816597

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Urinary excretion of NAG and FDP in acute renal graft rejection.
    Garcia B, Thompson AE, Tucker SM, Wing AJ.
    Proc Eur Dial Transplant Assoc; 1975; 11():311-9. PubMed ID: 1105552
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Clinical relevance of N-acetylglucosaminidase determination in urine of kidney transplant recipients with and without cyclosporin A].
    Loertscher R, Scholer A, Brunner F, Harder F, Thiel G.
    Schweiz Med Wochenschr; 1982 Nov 13; 112(46):1658-64. PubMed ID: 6760389
    [Abstract] [Full Text] [Related]

  • 5. Early diagnosis of rejection. Correlation of enzymuria and histological findings after renal transplantation in the rat.
    Asfar SK, Whiting PH, Simpson JG, Catto GR, Engeset J.
    Transplantation; 1984 Jun 13; 37(6):548-51. PubMed ID: 6375014
    [Abstract] [Full Text] [Related]

  • 6. Specific identification of urinary fibrinogen, fibrinogen degradation products, and cross-linked fibrin degradation products in renal diseases and after renal allotransplantation.
    Scott WL, Francis CW, Knutson DW, Marder VJ.
    J Lab Clin Med; 1986 Jun 13; 107(6):534-43. PubMed ID: 3519810
    [Abstract] [Full Text] [Related]

  • 7. [Determination of urinary N-acetyl-beta-D-glucosaminidase (NAG) excretion as a parameter of nephrotoxicity due to cis-platin and the effect of fosfomycin (FOM) on its nephrotoxicity].
    Matsuoka R, Inoue T, Miyamura K, Mizutani K, Koike S, Mori H, Kigawa T.
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Nov 13; 38(11):2037-44. PubMed ID: 3794453
    [Abstract] [Full Text] [Related]

  • 8. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 11. Clinical significance of urinary NAG activity in patients with kidney diseases and those with kidney homografts].
    Ishida Y, Kawada T, Sugino N.
    Rinsho Byori; 1983 Sep 13; Spec No 56():160-7. PubMed ID: 6363758
    [No Abstract] [Full Text] [Related]

  • 9. Clinical evaluation of urinary N-acetyl-beta-D-glucosaminidase activity in patients receiving aminoglycoside and cephalosporin drugs.
    Naruse T, Hirokawa N, Oike S, Maekawa T.
    Res Commun Chem Pathol Pharmacol; 1981 Feb 13; 31(2):313-29. PubMed ID: 7221185
    [Abstract] [Full Text] [Related]

  • 10. [Urinary N-acetyl-beta-D-glucosaminidase and gamma-glutamyl-transpeptidase activities for evaluation of renal disturbance in patients with multiple myeloma].
    Nishimura K, Kawada M, Suehiro T, Yamano T, Hashimoto K.
    Nihon Jinzo Gakkai Shi; 1992 Oct 13; 34(10):1087-94. PubMed ID: 1363243
    [Abstract] [Full Text] [Related]

  • 11. The excretion of N-acetyl-beta-glucosaminidase in glomerulonephritis.
    Hultberg B, Ravnskov U.
    Clin Nephrol; 1981 Jan 13; 15(1):33-8. PubMed ID: 7214750
    [Abstract] [Full Text] [Related]

  • 12. Urinary N-acetyl-beta-D-glucosaminidase in the patients with hyperthyroidism.
    Tominaga M, Fujiyama K, Hoshino T, Tanaka Y, Takeuchi T, Honda M, Mokuda O, Ikeda T, Mashiba H.
    Horm Metab Res; 1989 Aug 13; 21(8):438-40. PubMed ID: 2793065
    [Abstract] [Full Text] [Related]

  • 13. [Urinary excretion of N-acetyl-beta-D-glucosaminidase (NAG) and its isoenzyme B as a marker of the nephrotoxicity of gentamicin: re-test from an animal model].
    Ali-Miraftab H, Bourbouze R, Bondiou MT, Percheron F.
    Pathol Biol (Paris); 1988 Mar 13; 36(3):240-4. PubMed ID: 3283687
    [Abstract] [Full Text] [Related]

  • 14. [Influences of percutaneous nephrolithotomy on renal function, an observation using the NAG-index and beta 2-microglobulin as indices].
    Yajima I, Nishimura T, Yoshida K, Tomita M, Hikima N, Kawamura N, Tsuboi N, Honda R, Akimoto M.
    Hinyokika Kiyo; 1987 May 13; 33(5):662-8. PubMed ID: 3310555
    [Abstract] [Full Text] [Related]

  • 15. [Effects of intravenous urography using sodium and meglumine ioxitalamate (Telebrix 38) on blood creatinine and urinary excretion of N-acetyl-beta-D-glucosaminidase].
    Lacour B, Lacroix C, Jungers P, Bailly M.
    Ann Biol Clin (Paris); 1984 May 13; 42(6):407-11. PubMed ID: 6532266
    [Abstract] [Full Text] [Related]

  • 16. Beta-2-microglobulin is superior to N-acetyl-beta-glucosaminidase in predicting prognosis in idiopathic membranous nephropathy.
    Hofstra JM, Deegens JK, Willems HL, Wetzels JF.
    Nephrol Dial Transplant; 2008 Aug 13; 23(8):2546-51. PubMed ID: 18308774
    [Abstract] [Full Text] [Related]

  • 17. Melatonin reduces urinary excretion of N-acetyl-beta-D-glucosaminidase, albumin and renal oxidative markers in diabetic rats.
    Oktem F, Ozguner F, Yilmaz HR, Uz E, Dündar B.
    Clin Exp Pharmacol Physiol; 2006 Aug 13; 33(1-2):95-101. PubMed ID: 16445706
    [Abstract] [Full Text] [Related]

  • 18. [An early and specific indicator of aminoglycoside nephrotoxicity: isoenzyme B of urinary N-acetyl-beta-D-glucosaminidase (NAG)].
    Gibey R, Dupond JL, Peltier H, Iehl-Robert M, Henry JC.
    Pathol Biol (Paris); 1986 May 13; 34(5):342-5. PubMed ID: 3534703
    [Abstract] [Full Text] [Related]

  • 19. [Antineoplastic therapy and urinary enzymes. Preliminary note on the determination of urinary N-acetyl-beta-D-glucosaminidase in patients treated with cisplatin].
    Crovato E, Salvini R.
    Boll Soc Ital Biol Sper; 1984 Dec 30; 60(12):2255-60. PubMed ID: 6543318
    [Abstract] [Full Text] [Related]

  • 20. [Urinary excretion of N-acetyl-beta-D-glucosaminidase in patients with urological disease: with special reference to hydronephrosis].
    Ueda K, Kato J, Seki T.
    Hinyokika Kiyo; 1984 Jul 30; 30(7):877-82. PubMed ID: 6391119
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.